Skip to main content
Log in

Bioconversion of compactin into pravastatin by Streptomyces sp.

  • Published:
Biotechnology Letters Aims and scope Submit manuscript

Abstract

Streptomyces sp. Y-110, isolated from soil, modified compactin to pravastatin, a therapeutic agent for hypercholesterolemia. In a batch culture, the highest production of pravastatin was 340 mg l−1 from 750 mg compactin l−1 in 24 h. By intermittent feeding of compactin into the culture medium, both the compactin concentration and its conversion increased to 2000 mg l−1 and 1000 mg pravastatin l−1, respectively, with the conversion rate of 10 mg l−1 h−1. Continuous feeding of compactin increased production of pravastatin to 15 mg l−1 h−1.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Haruyuki Y, Tsubokawa S, Endo A (1985) Microbial hydroxylation of compactin (ML-236B) and monacolin K. J. Antibiotics 38: 605–609.

    Google Scholar 

  • Holt JG (1994) Bergey's Manual of Determinative Bacteriology, 9th edn. Baltmore: Williams and Wilkins Co.

    Google Scholar 

  • Masahiko H, Ogawa K, Yoshikawa H (1993) Application of computer to monitoring and control of fermentation process: microbial conversion of ML-236B Na to pravastatin. Biotechnol. Bioeng. 42: 815–820.

    Article  Google Scholar 

  • Omura T, Sato R (1964) The carbon monooxide-binding pigment of liver microsomes. J. Biol. Chem. 239: 2370–2378.

    PubMed  Google Scholar 

  • Park JW, Lee JK, Kwon TJ, YI DH, Park YI, Kang SM (2001) Purification and characterization of a cytochrome P-450 from pravatstatin-producing Streptomyses sp. Y-110. J. Microbiol. Biotechnol. 11: 1011–1017.

    Google Scholar 

  • Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macferlane PW, Mckillop JH, Packard CJ (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. New Engl. J. Med. 333: 1301–1309.

    PubMed  Google Scholar 

  • Shirling EB, Gottlieb D (1966) Methods for characterization of Streptomyces species. Int. J. Syst. Bacteriol. 16: 313–340.

    Google Scholar 

  • Willcox WB, Vapage SP, Bascomb S, Curtis MA (1973) Identification of bacteria by computer: theory and programming. J. Gen. Microbiol. 77: 317–310.

    PubMed  Google Scholar 

  • Williams ST, Goodfellow M, Alderson G, Wellington EMH, Sneath PHA, Sackin M (1983) Numerical classification of Streptomyces and related genera. J. Gen. Microbiol. 129: 1743–1813.

    PubMed  Google Scholar 

  • Williams ST, Sharpe ME, Holt JG, Murray RG, Brener DJ, Krieg NR, Mouldar JW, Pfenning N, Sneath PHA, Staley JT (1989) Bergey's Mannual of Systematic Bacteriology, Vol.4. Baltimore: William & Willkins Co.

    Google Scholar 

  • Yulin P, Yashphe J, Demain AL (1997) Biotransformation of compactin to pravastatin by Actinomadura sp. 2966. J. Antibiotics 50: 1032–1035.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yong-Il Park.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Park, JW., Lee, JK., Kwon, TJ. et al. Bioconversion of compactin into pravastatin by Streptomyces sp.. Biotechnology Letters 25, 1827–1831 (2003). https://doi.org/10.1023/A:1026281914301

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026281914301

Navigation